BioNano Genomics IncEquity-NMS: BNGO
Equity-NMS: BNGO
$0.46
+0.02
(5 Oct)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$0.46
Open
$0.46
Today’s high
$0.47
Today’s low
$0.44
52W low
$0.31
52W high
$3.0099
1Y
-82.90%
5Y
-41.03%
PE
0.04
EPS (TTM)
9.89
Shares O/S
86.00M
Market cap
39.56M
Insights
BNGO price is below its 200 day moving average
BNGO PE is in the lowest 10% across all stocks. The market is valuing it as a value stock on an earnings basis.
BNGO is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About BioNano Genomics Inc

Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc. , the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities.

It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV). .


FAQs

Can I buy BioNano Genomics Inc shares in India?
How to buy BioNano Genomics Inc shares in India?
What is the share price of BioNano Genomics Inc?
What is the Market Capitalization of BioNano Genomics Inc?
What is the PE ratio of BioNano Genomics Inc?
Is BioNano Genomics Inc a good stock to buy?
In which sector / industry does BioNano Genomics Inc operate?